Lantern Pharma
LTRN
$4.91
Share price
-8.57%
Change (1 day)
-18.30%
Change (1 year)
Categories
Lantern Pharma (LTRN) - P/B ratio
P/B ratio as of June 2024 : 1.48
According to Lantern Pharma's latest financial reports the company has a price-to-book ratio of 1.48.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Lantern Pharma - P/B ratio (from 2020 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.12 | -4.12% |
| 2022-12-31 | 1.17 | -6.19% |
| 2021-12-31 | 1.25 | -79.47% |
| 2020-12-31 | 6.08 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.53 | 3.34% | 🇺🇸 USA |